109 related articles for article (PubMed ID: 29683357)
1. Synthesis, screening and nanocrystals preparation of rhein amide derivatives.
Chen L; Zhang J; Rong J; Liu Y; Zhao J; Cui Q; Wang X; Liang X; Pan H; Liu H
J Microencapsul; 2018 Jun; 35(4):313-326. PubMed ID: 29683357
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight chitosan-based conjugates for efficient Rhein oral delivery: synthesis, characterization, and pharmacokinetics.
Luo J; Sun J; Luo X; Wei Y; Zheng H; Mu C; Yao W
Drug Dev Ind Pharm; 2019 Jan; 45(1):96-104. PubMed ID: 30196732
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and in vivo study of rhein solid lipid nanoparticles for oral delivery.
Feng H; Zhu Y; Fu Z; Li D
Chem Biol Drug Des; 2017 Nov; 90(5):867-872. PubMed ID: 28432812
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable nanoparticles for improved kidney bioavailability of rhein: preparation, characterization, plasma, and kidney pharmacokinetics.
Wei Y; Luo X; Guan J; Ma J; Zhong Y; Luo J; Li F
Drug Dev Ind Pharm; 2017 Nov; 43(11):1885-1891. PubMed ID: 28692315
[TBL] [Abstract][Full Text] [Related]
5. A novel β-cyclodextrin-rhein conjugate for improving the water solubility and bioavailability of rhein.
Wang J; Qian Y; Qian C; Shi F; Yao J; Bi X; Chen Z
Carbohydr Res; 2020 Apr; 490():107958. PubMed ID: 32120022
[TBL] [Abstract][Full Text] [Related]
6. Deoxycholic acid-functionalised nanoparticles for oral delivery of rhein.
Yao W; Xu Z; Sun J; Luo J; Wei Y; Zou J
Eur J Pharm Sci; 2021 Apr; 159():105713. PubMed ID: 33453389
[TBL] [Abstract][Full Text] [Related]
7. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-tumor activity evaluation of rhein-aloe emodin hybrid molecule.
Yuan YF; Hu XY; He Y; Deng JG
Nat Prod Commun; 2012 Feb; 7(2):207-10. PubMed ID: 22474959
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of anthraquinones in rat plasma after oral administration of a rhubarb extract.
Wu W; Yan R; Yao M; Zhan Y; Wang Y
Biomed Chromatogr; 2014 Apr; 28(4):564-72. PubMed ID: 24136708
[TBL] [Abstract][Full Text] [Related]
10. Solubility, spectroscopic properties and photostability of Rhein/cyclodextrin inclusion complex.
Petralito S; Zanardi I; Memoli A; Annesini MC; Travagli V
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Dec; 74(5):1254-9. PubMed ID: 19857988
[TBL] [Abstract][Full Text] [Related]
11. Effect of glycyrrhizic acid on rhein renal penetration: a microdialysis study in rats.
Wei Y; Guan J; Ma X; Zhong Y; Ma J; Li F
Xenobiotica; 2015; 45(12):1116-21. PubMed ID: 26042455
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic behavior of argirein, derived from rhein, is characterized as slow release and prolonged T₁/₂ of rhein in rats.
Cong XD; Fu PR; Dai DZ; Zhang Y; Dai Y
Eur J Pharm Sci; 2012 Aug; 46(5):468-74. PubMed ID: 22521276
[TBL] [Abstract][Full Text] [Related]
13. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
14. Preparation, in vitro and in vivo evaluation of bexarotene nanocrystals with surface modification by folate-chitosan conjugates.
Li L; Liu Y; Wang J; Chen L; Zhang W; Yan X
Drug Deliv; 2016; 23(1):79-87. PubMed ID: 24786485
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of rhein amides as inhibitors of osteoclast differentiation and bone resorption.
Xu X; Qi X; Yan Y; Qi J; Qian N; Guo L; Li C; Wang F; Huang P; Zhou H; Jiang M; Yang C; Deng L
Eur J Med Chem; 2016 Nov; 123():769-776. PubMed ID: 27541260
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous HPLC-UV determination of rhein and aceclofenac in human plasma.
Ojha A; Rathod R; Padh H
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1145-8. PubMed ID: 19299212
[TBL] [Abstract][Full Text] [Related]
17. Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies.
Fu Q; Sun J; Zhang D; Li M; Wang Y; Ling G; Liu X; Sun Y; Sui X; Luo C; Sun L; Han X; Lian H; Zhu M; Wang S; He Z
Colloids Surf B Biointerfaces; 2013 Sep; 109():161-6. PubMed ID: 23668980
[TBL] [Abstract][Full Text] [Related]
18. Reduced system exposures of total rhein and baicalin after combinatory oral administration of rhein, baicalin and berberine to beagle dogs and rats.
Wang Z; Hu H; Chen F; Lan K; Wang A
J Ethnopharmacol; 2013 Jan; 145(2):442-9. PubMed ID: 23159470
[TBL] [Abstract][Full Text] [Related]
19. [The pharmacokinetics of rhein in 12 healthy volunteers after oral administration of rhubarb extract].
Zhu W; Zhang L; Wang XM; Wang BX; Li XY
Zhongguo Zhong Yao Za Zhi; 2005 Sep; 30(18):1458-61. PubMed ID: 16381472
[TBL] [Abstract][Full Text] [Related]
20. Hyperoside nanocrystals for HBV treatment: process optimization, in vitro and in vivo evaluation.
Shen B; Wu N; Shen C; Zhang F; Wu Y; Xu P; Zhang L; Wu W; Lu Y; Han J; Wang Y; Yuan H
Drug Dev Ind Pharm; 2016 Nov; 42(11):1772-81. PubMed ID: 27032257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
